Thermo Fisher Scientific Inc. operates in the healthcare sector, providing essential solutions for life sciences and diagnostics around the globe. The company has a diverse portfolio and a strong presence in various significant markets. Let's delve into the fundamentals, historical performance, and analyst expectations for TMO.
This section provides a fundamental analysis of Thermo Fisher Scientific Inc., showcasing various financial ratios and performance scores.
Category | Score | Score Visualization |
---|---|---|
Overall | 3 | |
Discounted Cash Flow | 4 | |
Return on Equity | 4 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 2 | |
Price to Book | 2 |
Below are the financial scores of the previous and current dates representing Thermo Fisher Scientific Inc.'s historical performance.
Date | Overall | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
---|---|---|---|---|---|---|---|
2025-04-29 | 3 | 4 | 4 | 5 | 1 | 2 | 2 |
(Previous) | 0 | 4 | 4 | 5 | 1 | 2 | 2 |
The table below summarizes analyst price targets for Thermo Fisher Scientific Inc.
High | Low | Median | Consensus |
---|---|---|---|
$693 | $585 | $607.5 | $623.25 |
The table below provides insights into the distribution of analyst recommendations for Thermo Fisher Scientific Inc.
Recommendation | Count | Distribution |
---|---|---|
Strong Buy | 0 | |
Buy | 34 | |
Hold | 6 | |
Sell | 0 | |
Strong Sell | 0 |
Thermo Fisher Scientific Inc. showcases solid fundamentals with strengths in return on equity and assets, though it faces challenges with debt to equity. Analysts maintain a favorable "Buy" consensus, reflecting a strong market position. With solid historical performance and competitive pricing, the stock demonstrates potential for growth. However, attention should be given to financial leverage and market volatility. Overall, TMO presents a balanced risk-reward profile for potential investors.